Full-spectrum Endoscopy in Colorectal Cancer Screening

NCT ID: NCT02812550

Last Updated: 2016-06-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

249 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-05-31

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the adenoma detection rates of full-spectrum endoscopy versus standard forward-viewing colonoscopy in colorectal cancer screening programme.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Colorectal cancer is the third most common neoplasia and the second leading cause of cancer death in West countries. Colonoscopy is the gold standard for prevention of colorectal cancer disease. Screening for colorectal cancer with biennial faecal occult blood testing is a widely used strategy followed by colonoscopy for those with a positive test. Colonoscopy identifies polyps during the procedure as well as polyp removal in order to prevent progression to cancer. Although, interval cancer appears after a colonoscopy because of 22-28% of polyp missed rates. Advanced Technology may improve adenoma detection rates so decrease interval cancer and reduce mortally. Full-spectrum endoscopy with 330º angle vision decrease adenoma miss rate in general population.

The investigators conducted a randomized trial in patients from colorectal cancer screening programme (aged 50-69 years) after faecal immunological test positive. One arm the colonoscopy is performed with standard forward view colonoscopy (170º angle view) and the other arm is performed with full-spectrum endoscopy (EndoChoice) (330º angle view)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

full-spectrum colonoscopy

Colonoscopy is performed with a full-spectrum colonoscopy (330º angle of view)

Group Type OTHER

colonoscopy procedure

Intervention Type PROCEDURE

endoscopy performed with a standard forward view colonoscopy or with full-spectrum endoscopy

standar forward-viewing colonoscopy

Colonoscopy is performed with standar forward-viewing colonoscopy (170º angle of view)

Group Type OTHER

colonoscopy procedure

Intervention Type PROCEDURE

endoscopy performed with a standard forward view colonoscopy or with full-spectrum endoscopy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

colonoscopy procedure

endoscopy performed with a standard forward view colonoscopy or with full-spectrum endoscopy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patient referred for colorectal cancer screening with positive fecal inmunological test.
* Age between 50 and 69 years

Exclusion Criteria

* history of colonic resection,
* high risk for colorectal cancer like family history of colorectal cancer o polyposis syndrome,
* inflammatory bowel disease,
* patients with lower gastrointestinal bleeding symptoms,
* acute diverticulitis,
* colonic strictures,
* poor bowel preparation (Boston scale less than 5 points)
Minimum Eligible Age

50 Years

Maximum Eligible Age

69 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital del Rio Hortega

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mª Henar Núñez Rodriguez

Dra Mª Henar Núñez Rodriguez

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mª Henar Núñez Rodriguez, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Hospital del Rio Hortega Valladolid, Spain

References

Explore related publications, articles, or registry entries linked to this study.

Nunez-Rodriguez H, Diez-Redondo P, Perez-Miranda M, Gonzalez Sagrado M, Conde R, De la Serna C. Role of Full-spectrum Endoscopy in Colorectal Cancer Screening: Randomized Trial. J Clin Gastroenterol. 2019 Mar;53(3):191-196. doi: 10.1097/MCG.0000000000000975.

Reference Type DERIVED
PMID: 29283904 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GRS 1073/A/15

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CRC Detection Reliable Assessment With Blood
NCT05551052 ACTIVE_NOT_RECRUITING